Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Life Sci ; 182: 1-9, 2017 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-28591567

RESUMO

AIMS: Previous reports have demonstrated that alterations or reduced expression of Dystroglycan (Dg) complex (αDg and ßDg subunits) are related to progression and severity of neoplastic solid tissues. Therefore we determined the expression pattern and subcellular distribution of Dg complex in Acute Myeloid Leukemia (AML) primary blasts (M1, M2, and M3 phenotypes), as well as HL-60 and Kasumi-1 leukemia cell lines. Additionally, we evaluated the relative expression of the main enzymes controlling α-Dg glycosylation to ascertain the post-translational modifications in the leukemia cell phenotype. MAIN METHODS: Primary leukemia blasts and leukemia cell lines were processed by confocal analysis to determine the subcellular distribution of α-Dg, ß-Dg, and phosphorylated ß-Dg (Y892), to evaluate the expression pattern of the different Dg species we performed Western Blot (WB) assays, while the messenger RNA (mRNA) expression of enzymes involved in α-Dg glycosylation, such as POMGnT1, POMT1, POMT2, LARGE, FKTN, and FKRP, were evaluated by qualitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). Finally, in an attempt to ameliorate the leukemia cell phenotype, we transfected leukemia cells with a plasmid expressing the Dg complex. KEY FINDINGS: The Dg complex was altered in leukemia cells, including decreased mRNA, protein, and α-Dg glycosylated levels, mislocalization of ß-Dg, and a diminution of mRNA expression of LARGE in patients leukemia blasts and in cell lines. Interestingly, the exogenous expression of Dg complex promoted filopodial formation, differentiation, and diminished proliferation, attenuating some HL-60 and Kasumi cells characteristics. SIGNIFICANCE: Dg complex integrity and balance are required for a proper hematopoietic cell function, in that its disruption might contribute to leukemia pathophysiology.


Assuntos
Distroglicanas/genética , Regulação Neoplásica da Expressão Gênica , Leucemia Mieloide Aguda/patologia , Processamento de Proteína Pós-Traducional , Western Blotting , Diferenciação Celular/genética , Linhagem Celular Tumoral , Proliferação de Células/genética , Células HL-60 , Humanos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
2.
PLoS One ; 10(12): e0144078, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26630171

RESUMO

BACKGROUND: Dystroglycan has recently been characterised in blood tissue cells, as part of the dystrophin glycoprotein complex involved in the differentiation process of neutrophils. PURPOSE: In the present study we have investigated the role of dystroglycan in the human promyelocytic leukemic cell line Kasumi-1 differentiated to macrophage-like cells. METHODS: We characterised the pattern expression and subcellular distribution of dystroglycans in non-differentiated and differentiated Kasumi-1 cells. RESULTS: Our results demonstrated by WB and flow cytometer assays that during the differentiation process to macrophages, dystroglycans were down-regulated; these results were confirmed with qRT-PCR assays. Additionally, depletion of dystroglycan by RNAi resulted in altered morphology and reduced properties of differentiated Kasumi-1 cells, including morphology, migration and phagocytic activities although secretion of IL-1ß and expression of markers of differentiation are not altered. CONCLUSION: Our findings strongly implicate dystroglycan as a key membrane adhesion protein involved in actin-based structures during the differentiation process in Kasumi-1 cells.


Assuntos
Actinas/metabolismo , Diferenciação Celular/fisiologia , Distroglicanas/metabolismo , Linhagem Celular , Membrana Celular/metabolismo , Regulação para Baixo/fisiologia , Distrofina/metabolismo , Humanos , Interleucina-1beta/metabolismo , Macrófagos/metabolismo , Glicoproteínas de Membrana/metabolismo , Neutrófilos/metabolismo , Interferência de RNA/fisiologia
3.
Biochem Biophys Res Commun ; 448(3): 274-80, 2014 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-24792180

RESUMO

Dystroglycan has recently been characterized in blood tissue cells, as part of the dystrophin glycoprotein complex but to date nothing is known of its role in the differentiation process of neutrophils. We have investigated the role of dystroglycan in the human promyelocytic leukemic cell line HL-60 differentiated to neutrophils. Depletion of dystroglycan by RNAi resulted in altered morphology and reduced properties of differentiated HL-60 cells, including chemotaxis, respiratory burst, phagocytic activities and expression of markers of differentiation. These findings strongly implicate dystroglycan as a key membrane adhesion protein involved in the differentiation process in HL-60 cells.


Assuntos
Diferenciação Celular/fisiologia , Distroglicanas/fisiologia , Neutrófilos/citologia , Neutrófilos/fisiologia , Biomarcadores/metabolismo , Movimento Celular , Quimiotaxia de Leucócito , Distroglicanas/antagonistas & inibidores , Distroglicanas/genética , Células HL-60 , Humanos , Fagocitose , Fenótipo , Interferência de RNA , RNA Interferente Pequeno/genética , Explosão Respiratória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA